Tuberculosis in Mumbai

TB Day 2025 by MSF in Mumbai: Reimagining drug-Resistant TB care through equity, innovation, and community leadership

by

12 May 2025, Mumbai: Médecins Sans Frontières (MSF)/Doctors Without Borders South Asia convened the 4th edition of its Tuberculosis (TB) Day on May 12, 2025, in Mumbai, India, bringing together over 200 medical experts, TB survivors, policymakers, researchers, and civil society leaders from across South Asia. This year’s gathering comes at a pivotal moment as … Read more

India: Mumbai TB Symposium Focuses on Advancing TB Treatment and Collaboration

by

10 June 2024, Mumbai: A pivotal symposium organised today by Médecins Sans Frontières (MSF)/Doctors Without Borders brought together a diverse coalition of experts and stakeholders to forge actionable strategies against Drug-Resistant Tuberculosis (DRTB). This crucial gathering aimed to highlight the key successes and challenges in the battle against TB, with an emphasis on enhancing the … Read more

India: How Deepak Shegar overcame DR-TB to reclaim his dreams

by

Mumbai, India- “When I recover, I want to play cricket,” says Deepak Shegar, a 23-year-old whose aspirations extend far beyond his battle with drug-resistant tuberculosis (DR-TB). With dreams of a career in the garment industry, a love for cricket, and a desire for a brand-new bike, Deepak’s journey to pursue his goals has been long … Read more

Deepak Shegar: Battling DR-TB with resilience and dreams

by

“When I recover, I want to play cricket,” says Deepak Shegar, a 23-year-old whose aspirations extend far beyond his battle with drug-resistant tuberculosis (DR-TB). With dreams of a career in the garment industry, a love for cricket, and a desire for a brand-new bike, Deepak’s journey to pursue his goals has been long and challenging. … Read more

Namrata’s Journey: Triumph Over Drug-Resistant Tuberculosis

by

Namrata’s story is a testament to the timeless principle that consistency is crucial. Her disciplined approach to maintaining a routine, embracing a healthy lifestyle, and adhering to medication regimens demonstrates that even conditions like drug-resistant tuberculosis (DR-TB) can be overcome. In 2016, Namrata was employed at a daycare in an international school in Chembur, Mumbai. … Read more

MSF: TB test price reduction by Cepheid and Danaher is an important step in the right direction

by

Cepheid and its parent company Danaher announced today that they are reducing the price of the Xpert MTB/RIF test for TB by 20 percent in high-TB-burden countries from US$9.98 to $7.97 per test.  This reduction is a significant step, considering the corporations have refused to reduce the price of this test for over ten years. While … Read more

Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need

by

TB is curable but remains the world’s leading infectious disease killer 12 September 2023, Geneva/New York – Next week, world leaders meet for the second-ever global tuberculosis (TB) High-Level Meeting at the United Nations (UN) in New York, to endorse ambitious commitments to ramp up TB testing, treatment and prevention in light of innovative medical … Read more

Global TB Report 2022: MSF calls for scale up of shorter and safer DR-TB treatments to help save more lives

by

The World Health Organization (WHO) released today the 2022 edition of its Global Tuberculosis (TB) Report, featuring data on the TB response and trends in 215 countries and areas. Among the alarming trends from 2021, there is an increase in the estimated incidence of TB for the first time in two decades, including for the more difficult … Read more

Renewed hope- Stories of four patients fighting drug-resistant-TB in Mumbai

by

Name : Designation : Interviews conducted & written by DVL Padma Priya for MSF   For World TB Day 2018, we celebrate the courage and endurance of four MSF patients who are currently undergoing treatment for drug-resistant TB (DR-TB).  Pooja, Rekha, Vikas and Sita are receiving care in MSF’s DR-TB programme in Mumbai, where a … Read more

India: Renewed hope with new drugs

by

Two new drugs, bedaquiline and delamanid, are proving to be the very last lifeline for tuberculosis (TB) patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able to access them as they are not widely available. Nischaya, eighteen years old, receives the … Read more